HSIC · Henry Schein Inc
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HSIC
this stock
Henry Schein Inc
|
$9.63B | +11.1% | +5.9% | 25.2 | 6.8% |
|
MCK
Mckesson Corp
|
$101.04B | +4.1% | +3.1% | 23.3 | 2.5% |
|
COR
Cencora, Inc.
|
$57.74B | -11.1% | +9.3% | 22.5 | 2.3% |
|
CAH
Cardinal Health Inc
|
$52.08B | +8.3% | +14.2% | — | 2.9% |
|
EBOSY
EBOS Group Limited/ADR
|
$2.41B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HSIC | -1.3% | -5.1% | +11.0% | -6.5% | +11.1% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | -0.6% | -5.3% | -1.1% | -5.9% | -0.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.